Description:
Home Page: www.poxelpharma.com
0RA2 Technical Analysis
Immeuble Le Sunway
Lyon,
69007
France
Phone:
33 4 37 37 20 10
Officers
| Name | Title |
|---|---|
| Mr. Thomas Kuhn M.B.A., Pharm.D., Pharm D MBA | Co-Founder, CEO & Director |
| Dr. Sébastien Bolze Ph.D., Pharm.D., Pharm D Ph.D. | Co-Founder, COO & Exec. VP |
| Dr. Pascale Fouqueray-Grellier M.D., Ph.D. | Co-Founder and Exec. VP of Clinical Devel. & Regulatory Affairs |
| Dr. Sophie Hallakou-Bozec Ph.D. | Co-Founder and Sr. VP of R&D Pharmacology & Scientific Communication |
| Ms. Anne Renevot | Exec. VP & CFO |
| Dr. David E. Moller M.D. | Exec. VP & Chief Scientific Officer |
| Ms. Elizabeth Woo M.B.A. | Sr. VP of Investor Relations, Corp. Communications & PR |
| Mr. Quentin Durand | Exec. VP, Chief Legal Officer & Head of CSR |
| Sylvie Bertrand | VP of HR |
| Mr. Noah D. Beerman MBA | Exec. VP of Bus. Devel. & Pres of US Operations |
Exchange: LSE
Country: GB
Currency: Euro (€)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.2555 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 15 |